Found: 5
Select item for more details and to access through your institution.
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 7, p. 1863, doi. 10.1007/s13555-024-01195-z
- By:
- Publication type:
- Article
Effectiveness of romosozumab in patients with osteoporosis at high fracture risk: a Japanese real-world study.
- Published in:
- Journal of Bone & Mineral Metabolism, 2024, v. 42, n. 1, p. 77, doi. 10.1007/s00774-023-01477-0
- By:
- Publication type:
- Article
Efficacy and safety of romosozumab among Japanese postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease.
- Published in:
- Journal of Bone & Mineral Metabolism, 2022, v. 40, n. 4, p. 677, doi. 10.1007/s00774-022-01332-8
- By:
- Publication type:
- Article
Romosozumab followed by denosumab in Japanese women with high fracture risk in the FRAME trial.
- Published in:
- Journal of Bone & Mineral Metabolism, 2021, v. 39, n. 2, p. 278, doi. 10.1007/s00774-020-01147-5
- By:
- Publication type:
- Article
Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension.
- Published in:
- Archives of Osteoporosis, 2019, v. 14, n. 1, p. N.PAG, doi. 10.1007/s11657-019-0608-z
- By:
- Publication type:
- Article